Product Information
ACETAMINOPHEN 325 MG TABLET is a generic product labeled by Rugby Laboratories, priced at $0.0233 per EA under NDC 00536132701. Its NADAC has been published 281 times since May 19, 2021.
Strength
325 mg/1
Manufacturer
Rugby LaboratoriesNDC
00536132701
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHENApproval Type
OTC MONOGRAPH DRUG
FDA Application
M013On Market Since
3/11/2021
Price Statistics
The NADAC for ACETAMINOPHEN 325 MG TABLET has been published 281 times since May 19, 2021, and over the history we have for it it has risen 30.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0233 per EA |
|---|---|
| All-time high | $0.0267 (Nov 13, 2024) |
| All-time low | $0.0180 (May 19, 2021) |
| 52-week high | $0.0267 |
| 52-week low | $0.0233 |
| Median price | $0.0243 |
| Average price | $0.0241 |
| Largest weekly change | +33.8% (Jun 23, 2021) |
| Weeks tracked | 281 |
| Tracking since | May 19, 2021 |
Generic Alternatives
The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Rugby Laboratories manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Acetaminophen market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ACETAMINOPHEN 325 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ACETAMINOPHEN 325 MG TABLET, manufactured by Rugby Laboratories, is $0.0233 per EA (NDC 00536132701), effective Sep 30, 2026.
How has the price of ACETAMINOPHEN 325 MG TABLET changed over time?
Over the history we have for it, the NADAC for ACETAMINOPHEN 325 MG TABLET has risen 30.0%. It has been tracked across 281 weekly CMS publications since May 19, 2021.
What are the highest and lowest recorded NADAC prices for ACETAMINOPHEN 325 MG TABLET?
Since May 19, 2021, the NADAC for ACETAMINOPHEN 325 MG TABLET has ranged from a low of $0.0180 (May 19, 2021) to a high of $0.0267 (Nov 13, 2024), with a median of $0.0243 per EA.
Are there cheaper alternatives to ACETAMINOPHEN 325 MG TABLET?
Yes. 8 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QC PAIN RELIEF 325 MG TABLET, is $0.0232 per EA — about 1% below ACETAMINOPHEN 325 MG TABLET.
Who manufactures ACETAMINOPHEN 325 MG TABLET?
ACETAMINOPHEN 325 MG TABLET (NDC 00536132701) is labeled by Rugby Laboratories, and CMS classifies it as a generic product.